11.02.2019 | Understanding the Disease
Myotrauma in mechanically ventilated patients
Erschienen in: Intensive Care Medicine | Ausgabe 6/2019
Einloggen, um Zugang zu erhaltenExcerpt
In 1988, Knisely et al. “noted marked thinning of the muscular portions of the diaphragm” in neonates following prolonged mechanical ventilation [1]. This provided the first evidence that adverse patient–ventilator interactions can cause deleterious structural changes in the diaphragm, a phenomenon recently termed myotrauma [2]. Extensive experimental and clinical investigation has confirmed the existence of myotrauma and characterized its prevalence and clinical impact [2, 3]. Diaphragm myotrauma is a serious concern because it leads to acute diaphragm weakness (referred to as ventilator-induced diaphragm dysfunction; see Table 1 for terminology) and can therefore impair patients’ ability to be liberated from mechanical ventilation. Prolonged mechanical ventilation predisposes patients to nosocomial complications and strongly predicts long-term morbidity and mortality [4]. Preventing myotrauma might therefore accelerate liberation from mechanical ventilation and significantly improve outcomes for critically ill patients. This paper focuses on the adverse patient–ventilator interactions involved in myotrauma and their implications for management; the cellular pathways have recently been reviewed [3, 5].
ICU-acquired weakness
|
Generalized muscle weakness developing in the context of critical illness and ICU admission; usually employed to refer to axial skeletal muscle weakness but encompasses all forms of muscle weakness
|
Critical illness-associated
diaphragm weakness
|
Diaphragm weakness (loss of force-generating capacity) occurring in the critically ill regardless of the cause and timing; includes the effects of sepsis, drugs, mechanical ventilation, and other ICU exposures
|
Ventilator-induced diaphragm dysfunction
|
An acute loss of force-generating capacity in the diaphragm specifically due to mechanical ventilation
|
Myotrauma
|
Various adverse patient–ventilator interactions leading to diaphragm atrophy and injury, resulting in a final common pathway of diaphragm weakness (ventilator-induced diaphragm dysfunction). Analogous to volutrauma or atelectrauma in ventilator-induced lung injury
|